지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2008.1
- 수록면
- 77 - 81 (5page)
이용수
초록· 키워드
오류제보하기
The major aim of the Korean Pharmacogenomic Database (KPD) is to offer to users a "bridging" function, making the search for useful information easier. This database has also been established to collect unique Korean genotype data from other databases and to directly link these data to other major databases that offer more informative data. In this way, searches for information about new drug developments and easier and faster evaluation of the more complex and larger databases are possible. The KPD is located at the National Institute of Toxicological Research homepage (http://www.nitr.go.kr/nitr/contents/m134700/view.do), and offers Korean single-nucleotide polymorphism (SNP) information for 154 genes and haplotype information. It also compares the Korean SNP and haplotype frequencies with those of the other ethnic groups registered in the International HapMap. Through the Pharmacogenomic Information and Education facility, we also provide evaluators and the public with information about the concept of pharmacogenomic information, research trends, and the drug regulations of other countries. Because the drug responses of Koreans are not necessarily the same as those of Chinese or Japanese people, it is expected that the systematic operation of the KPD will allow the definition of racial differences and various genomic biomarkers (haplotypes or SNPs) for use in bridging studies and in the approval of new drugs.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Introduction to Pharmacogenomics in New Drug Development
한국응용약물학회 추계학술발표논문집
2005 .01
-
CANCER PHARMACOGENOMICS
한국응용약물학회 추계학술발표논문집
2005 .01
-
The Present Situation of Pharmacogenomics in Japan and a Pharmacogenomic Study of Irinotecan
한국응용약물학회 추계학술발표논문집
2006 .01
-
Overview of Pharmacogenomics
대한임상약리학회 심포지움
2002 .01
-
Pharmacogenomics in Clinical Trials
한국응용약물학회 추계학술발표논문집
2005 .01
-
Regulatory Perspectives on Pharmacogenomics
한국응용약물학회 추계학술발표논문집
2006 .01
-
Regulatory Perspectives on Pharmacogenomics
대한임상약리학회 심포지움
2008 .01
-
Drug Development in the age of pharmacogenomics: Issues facing Japan for genomics based drug development
한국응용약물학회 추계학술발표논문집
2005 .01
-
Pharmacogenomics in Relation to Tailor-made Drugs
The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology
2006 .01
-
Pharmacogenomics of drug disposition: integrated understanding of gene-environmental interaction
한국응용약물학회 추계학술발표논문집
2005 .01
-
PHARMACOGENOMICS IN RELATION TO TAILOR-MADE DRUGS -INTRODUCTION-
한국응용약물학회 추계학술발표논문집
2006 .01
-
Pharmacogenomics of Active Tamoxifen Metabolites
대한임상약리학회 학술대회
2004 .01
-
약물유전체학과 정신분열병
생물정신의학
2001 .01
-
천식 약물유전체 연구에서 시스템 생물학 접근
Allergy Asthma & Respiratory Diseases
2014 .01
-
CYP2C19 Pharmacogenomics-based Helicobacter pylori eradication the therapy by proton pump inhibitors
대한임상약리학회 심포지움
2002 .01
-
Pharmacogenetic/Pharmacogenomic Approaches of Active Tamoxifen Metabolites for Better Individualized Treatment of Breast Cancer
대한임상약리학회 학술대회
2006 .01
-
Pharmacogenomic Association Study between Genetic Polymorphic Variations of MDR-1 and CYP3A5 and Efficacy and Adverse Drug Reactions of Calcinuerin Inhibitors
한국응용약물학회 추계학술발표논문집
2006 .01
-
약물대사효소의 유전적 다형성 및 임상적 응용
한국임상약학회지
2006 .01
-
Progress in the Direct Application of Pharmacogenomics to Patient Care: Sustaining innovation
The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology
2007 .01
-
Association of the Promoter Haplotype of IFN-γ-Inducible Protein 16 Gene with Schizophrenia in a Korean Population
PSYCHIATRY INVESTIGATION
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0